IRIS
GALEAZZI, MAURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 42.411
EU - Europa 32.437
AS - Asia 15.574
SA - Sud America 2.818
AF - Africa 712
Continente sconosciuto - Info sul continente non disponibili 597
OC - Oceania 47
AN - Antartide 1
Totale 94.597
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 41.889
GB - Regno Unito 9.316
CN - Cina 5.815
RU - Federazione Russa 4.982
SG - Singapore 4.792
IT - Italia 4.209
IE - Irlanda 3.639
UA - Ucraina 2.770
BR - Brasile 2.329
SE - Svezia 2.072
FR - Francia 1.862
DE - Germania 1.835
VN - Vietnam 1.344
HK - Hong Kong 1.175
FI - Finlandia 898
KR - Corea 710
IN - India 350
BD - Bangladesh 338
ZA - Sudafrica 323
CA - Canada 255
TR - Turchia 175
AR - Argentina 163
ES - Italia 161
IQ - Iraq 151
NL - Olanda 145
MX - Messico 126
PL - Polonia 109
NG - Nigeria 106
JP - Giappone 101
BE - Belgio 97
ID - Indonesia 81
EC - Ecuador 77
CI - Costa d'Avorio 70
PK - Pakistan 67
VE - Venezuela 63
CO - Colombia 62
CZ - Repubblica Ceca 57
MA - Marocco 51
SA - Arabia Saudita 49
UZ - Uzbekistan 44
AT - Austria 43
AU - Australia 37
CL - Cile 36
TN - Tunisia 36
MY - Malesia 35
PH - Filippine 35
LT - Lituania 34
NP - Nepal 33
AE - Emirati Arabi Uniti 31
KE - Kenya 30
JO - Giordania 29
EG - Egitto 27
KZ - Kazakistan 26
PY - Paraguay 26
CR - Costa Rica 25
EU - Europa 25
IR - Iran 25
PE - Perù 25
GR - Grecia 24
JM - Giamaica 24
CH - Svizzera 22
IL - Israele 21
DZ - Algeria 20
UY - Uruguay 20
BG - Bulgaria 19
RO - Romania 19
AL - Albania 18
AZ - Azerbaigian 16
DO - Repubblica Dominicana 16
DK - Danimarca 15
BO - Bolivia 14
HN - Honduras 14
KG - Kirghizistan 13
PT - Portogallo 13
TH - Thailandia 13
LB - Libano 12
GT - Guatemala 11
KW - Kuwait 11
TT - Trinidad e Tobago 11
ET - Etiopia 10
HU - Ungheria 10
OM - Oman 10
RS - Serbia 10
BH - Bahrain 9
SK - Slovacchia (Repubblica Slovacca) 9
SY - Repubblica araba siriana 9
NI - Nicaragua 8
HR - Croazia 7
PA - Panama 7
PS - Palestinian Territory 7
SV - El Salvador 7
AM - Armenia 6
LU - Lussemburgo 6
LV - Lettonia 6
NZ - Nuova Zelanda 6
TW - Taiwan 6
AO - Angola 5
BY - Bielorussia 5
CY - Cipro 5
EE - Estonia 5
Totale 93.915
Salva come PNG Salva come JPEG
Città #
Southend 8.589
Dallas 4.395
Fairfield 3.998
Dublin 3.600
Ashburn 3.177
Singapore 2.742
Menlo Park 2.428
Chandler 2.255
Jacksonville 2.242
Woodbridge 1.906
Houston 1.885
Wilmington 1.547
Santa Clara 1.524
Seattle 1.508
Beijing 1.361
Cambridge 1.342
Moscow 1.302
San Jose 1.249
Milan 1.209
Ann Arbor 1.163
Hong Kong 1.124
Council Bluffs 886
Nanjing 763
Princeton 736
Hefei 725
Seoul 683
The Dalles 682
Siena 529
New York 519
Los Angeles 479
Rome 427
Ho Chi Minh City 420
Lauterbourg 388
Helsinki 381
Boardman 335
Hanoi 328
San Mateo 316
Johannesburg 291
Munich 281
San Diego 252
Nanchang 251
Columbus 248
Buffalo 246
São Paulo 216
Dearborn 181
Shenyang 178
Düsseldorf 162
Shanghai 149
Tianjin 133
Changsha 130
Hebei 127
Figino 126
Orem 115
Venezia 107
Jiaxing 106
Abuja 102
London 96
Málaga 96
Brussels 90
Dong Ket 90
Kunming 90
Turku 89
Lancaster 88
Toronto 88
San Francisco 86
Tokyo 84
Jinan 83
Frankfurt am Main 81
Chicago 79
Guangzhou 79
Rio de Janeiro 78
Warsaw 76
Brooklyn 75
Boston 73
Bengaluru 71
Chennai 71
Abidjan 70
Norwalk 69
Redondo Beach 68
Belo Horizonte 67
Florence 65
Montreal 65
Washington 65
Zhengzhou 65
Da Nang 64
Turin 62
Izmir 60
Denver 56
Phoenix 55
Saint Petersburg 53
Atlanta 52
Baghdad 52
Haiphong 50
Hangzhou 50
Mestre 50
Ningbo 50
Stockholm 47
Bologna 45
Brasília 45
Falls Church 45
Totale 65.577
Salva come PNG Salva come JPEG
Nome #
UNIREUMA -REUMATOLOGIA PER STUDENTI E MEDICI DI MEDICINA GENERALE I EDIZIONE 709
Livello sierico della COMP (Cartilage Oligomeric Matrix Protein): Uso potenziale come marker di progressione del danno articolare nei pazienti con "Early Rheumatoid Arthritis" 489
Comparison of combination therapies in the treatment of rheumatoid arthritis :leflunomide-anti-TNF-alfa versus methotrexate-anti-TNF-alfa 481
Arrhythmogenicity of Anti-Ro/SSA antibodies in patients with torsades de pointes 426
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 413
null 412
Antiarrhythmic potential of anticytokine therapy in rheumatoid arthritis: tocilizumab reduces corrected QT interval by controlling systemic inflammation 407
Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system 405
Ajulemic acid exerts potent anti-fibrotic effect during the fibrogenic phase of bleomycin lung 398
Diagnostic accuracy of currently available anti-double-stranded DNA antibody assays. An Italian multicentre study 379
Expression of RXFP1 in skin of scleroderma patients and control subjects 374
A "new" technique for the diagnosis of chondrocalcinosis of the knee: sensitivity and specificity of high-frequency ultrasonography 371
Eosinophilia-associated muscle disorders:an immunohistological study with tissue localisation of major basic protein in distinct clinicopathological forms 369
AB0969 Accuracy of blind intra-articular injections in patients with osteoarthritis of the knee. An ultrasonography controlled study 360
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: A four-year follow-up study 357
Alkaptonuria is a novel human secondary amyloidogenic disease 356
Adalimumab effectiveness in Behçet’s disease: short and long-term data from a multicenter retrospective observational study 352
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 347
AB0535 Effects of tocilizumab on bone density and metabolism in patients with active rheumatoid arthritis 339
A novel ex vivo organotypic culture model of alkaptonuria-ochronosis 329
A case of amyloid myopathy in a patient with familial Mediterranean fever 329
Bone mineral density in patients with systemic sclerosis. 326
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α 323
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis 323
Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis 323
Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry 322
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 322
Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity 321
Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review 321
Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes 320
Ten-Year Retention Rate of Infliximab in Patients with Behçet’s Disease-Related Uveitis 320
Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project" 317
Absence of anti-cyclic citrullinated peptide antibodies in erosive osteoarthritis: further serological evidence of the disease as a subset of osteoarthritis 317
Deltoideal acromial enthesopathy in ankylosing spondylitis and in spondylarthropathies: comment on the article by Lambert et al. 315
Change perspective to increase diagnostic accuracy of ultrasonography in calcium pyrophosphate dehydrate deposition disease! A new approach: The axial scan of the meniscus 314
Circulating levels of adiponectin, resistin, and visfatin after mud-bath therapy in patients with bilateral knee osteoarthritis 309
Anti-cofactor autoantibodies in systemic lupus erythematosus: prevalence, clinical and HLA class II associations 309
Colchicine myopathy and neuromyopathy: two cases with different characteristics 308
Intravenous immunoglobulins and antiphospholipid syndrome: How, when and why? A review of the literature 308
High levels of maternal serum IL-17 and activin A in pregnant women affected by systemic lupus erythematosus 307
A case of resistant adult-onset periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome responsive to anakinra. 305
AB1308 Prevalence of baker’s CYST in patients with chronic gonalgia and relationship with major non inflammatory diseases 304
Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis 303
Biological treatments: new weapons in the management of monogenic autoinflammatory disorders 303
Could oxidative stress regulate the expression of microRNA-146a and microRNA-34a in human osteoarthritic chondrocyte cultures? 303
Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis 302
Obesity reduces the response rate to anti TNFα in rheumatoidarthritis. an approach to a personalized medicine 302
Low serum level of COMP, a cartilage turnover marker, predicts rapid and high ACR70 response to adalimumab therapy in rheumatoid arthritis 301
Diagnosis of calcium pyrophosphate dihydrate crystal deposition disease: ultrasonographic criteria proposed. 300
Safety of cyclosporin A in HCV-infected patients: experience with cyclosporin A in patients affected by rheumatological disorders and concomitant HCV infection 298
Validation of an Italian version of the functional index for hand osteoarthritis (FIHOA) 298
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 298
A whitish-creamysynovial fluid. 297
Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults 297
Ultrasonography and magnetic resonance imaging of heel fat pad inflammatory-oedematous lesions in rheumatoid arthritis 293
Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications 292
Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseases: Response to: Nikiphorou E, Kautiainen H, Hannonen P, et al. Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data. Expert Opin Biol Ther. 2015;15:1677–1683 288
Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus 287
FRI0501 Ultrasound versus synovial fluid analysis for the diagnosis of calcium pyrophosphate dihydrate deposition disease: preliminary results 286
Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis 286
The Immunogenetics of the Antiphospholipid Syndrome, Anticardiolipin Antibodies, and Lupus Anticoagulant 283
Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study 281
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 280
Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation 278
One-year follow-up of mud-bath therapy in patients with bilateral knee osteoarthritis: a randomized, single-blind controlled trial 277
Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: Clinical, serological, and HLA class II gene associations 273
The diagnostic evaluation of patients with a suspected hereditary periodic fever syndrome: experience from a referral center in Italy 273
Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin 273
Cyclosporine A for the treatment of autoimmune disorders in HCV infected patients 270
Long-term safety of anti-TNF agents on the liver of patients with spondyloarthritis and potential occult hepatitis B viral infection: An observational multicentre study 270
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial. 269
A loss-of-function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus 269
Calcaneus ultrasonometry and dual-energy X-ray absorptiometry for the evaluation of vertebral fracture risk 269
Granulomatosis with polyangiitis and intravenous immunoglobulins: A case series and review of the literature 268
Effects of tumor necrosis factor-α inhibitors in mothers and daughters concordant for HLA-B27-positive ankylosing spondylitis 265
Challenges and new horizons in the periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome 265
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet’s Disease 264
Hydrostatic pressure regulates MicroRNA expression levels in osteoarthritic chondrocyte cultures via the Wnt/β-catenin pathway 264
Anomalie cromosomiche, valutate come frequenza di micronuclei spontanei, in soggetti con fenomeno di Raynaud sospetto presclerodermico [Chromosome aberrations, valued as frequency of spontaneous micronuclei, in subjects with suspected presclerodermic Raynaud's phenomenon] 263
Anticardiolipin and antibeta2GPI antibodies In a large series of european patients with systemic lupus erythematosus: prevalence and clinical association 262
Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease 262
Can hybrid hyaluronic acid represent a valid approach to treat rizoarthrosis? A retrospective comparative study 261
SAT0564 Articular Involvement in Behçet Disease: An Ultrasonographic Study 260
SAT0312 Ultrasound Reliability in the Diagnosis of Calcium Pyrophosphate Deposition Disease: Agreement Between Observers and Main Causes of Discordance 260
Chromosomal abnormalities in peripheral lymphocytes from idiopathic Raynaud's phenomenon patients 258
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema 258
Association of extrahepatic manifestations with HLA class II alleles and with virus genotype in HCV infected patients 257
Mechanisms of action of spa therapies in rheumatic diseases: what scientific evidence is there? 255
Safety and efficacy of etanercept in children with juvenile-onset Behcets disease 255
FRI0533 Ultrasonographic Features of Joints and Entheses in Healty Children 254
Cartilage oligomeric matrix protein level in rheumatic diseases: potential use as a marker for measuring articular cartilage damage and/or the therapeutic efficacy of treatments 253
A placebo-controlled study of the efficacy and tolerability of a nonsteroidal anti-inflammatory drug, DHEP plaster, in inflammatory peri- and extra-articular rheumatological diseases 252
Arrhythmic risk during acute infusion of infliximab: a prospective, single-blind, placebo-controlled, cross-over study in patients with chronic arthritis 251
SAT0542 The Prevalence of Calcium Pyrophosphate Deposits at Ultrasound Examination: Retrospective Analysis in A Cohort of Patients 251
Viral genotype and HLA class II alleles influence on extra-hepatic manifestations of chronic HCV infection 251
Autoinflammatory disorders and patients with isolated serosal involvement. 250
Weekly oral alendronate in mevalonate kinase deficiency 250
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 250
Chromosome aberrations in Raynaud's phenomenon 249
Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies 247
Totale 30.870
Salva come PNG Salva come JPEG
Categoria #
all - tutte 274.903
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 274.903
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.001 0 0 428 492 430 157 258 244 441 737 589 1.225
2022/20238.015 533 577 1.075 1.184 870 1.650 108 628 832 164 255 139
2023/20245.268 231 130 438 299 187 1.548 1.750 142 24 61 71 387
2024/202510.488 229 608 856 615 1.281 529 250 616 844 403 1.257 3.000
2025/202626.188 1.945 3.988 3.086 2.862 4.777 1.126 2.619 751 747 1.183 600 2.504
2026/20272.756 1.275 1.044 437 0 0 0 0 0 0 0 0 0
Totale 94.597